World's Best Scientists 2026 revealed!
Livio Trentin

Livio Trentin

D-Index & Metrics

Immunology

D-Index
74
Citations
18447
World Ranking
2061
National Ranking
80

Livio Trentin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Livio Trentin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 598 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Livio Trentin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Livio Trentin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Livio Trentin is affiliated with the University of Padua in Italy. Their research primarily focuses on Medicine, with substantial contributions in related subfields such as Genetics, Pathology and Forensic Medicine, Immunology, Oncology, and Hematology.

Their scientific work centers on topics including Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Advanced Breast Cancer Therapies, Immune Cell Function and Interaction, Chronic Myeloid Leukemia Treatments, and Viral-associated cancers and disorders.

Trentin has published papers in several prominent journals. Notable papers include:

  • COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus (2020, Leukemia)
  • Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort (2022, Blood)
  • Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL (2020, Blood)
  • Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca 2+ -dependent death of cancer cells (2020, EMBO Reports)
  • COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study (2021, Leukemia)

Frequent co-authors collaborating with Trentin include:

  • Andrea Visentin
  • Marta Coscia
  • Francesca Romana Mauro
  • Paolo Sportoletti
  • Francesco Piazza

Trentin's work has appeared repeatedly in key publication venues. These include:

  • Blood
  • HemaSphere
  • Hematological Oncology
  • Frontiers in Oncology
  • Cancers

Best Publications

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

    Andrea Gallamini;Martin Hutchings;Luigi Rigacci;Lena Specht

  • The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease

    Andrea Gallamini;Luigi Rigacci;Francesco Merli;Luca Nassi

  • Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis

    Antonella Contri;Anna Maria Brunati;Livio Trentin;Anna Cabrelle

  • The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.

    Andrea Gallamini;Sally F. Barrington;Alberto Biggi;Stephane Chauvie

  • COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.

    Lydia Scarfò;Thomas Chatzikonstantinou;Gian Matteo Rigolin;Giulia Quaresmini

  • Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection

    Carlo Agostini;Fiorella Calabrese;Federico Rea;Monica Facco

  • Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

    Panagiotis Baliakas;Sabine Jeromin;Michalis Iskas;Anna Puiggros

  • Involvement of the IP-10 Chemokine in Sarcoid Granulomatous Reactions

    Carlo Agostini;Marco Cassatella;Renato Zambello;Livio Trentin

  • Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

    Andrea Gallamini;Corrado Tarella;Simonetta Viviani;Andrea Rossi;Andrea Rossi

  • ROLE OF IL-15, IL-2 AND THEIR RECEPTORS IN THE DEVELOPMENT OF T CELL ALVEOLITIS IN PULMONARY SARCOIDOSIS

    C Agostini;L Trentin;M Facco;R Sancetta

  • The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions

    G. Semenzato;F. Pandolfi;T. Chisesi;G. De Rossi

  • THE CHEMOKINE RECEPTOR CXCR3 IS EXPRESSED ON MALIGNANT B CELLS AND MEDIATES CHEMOTAXIS

    Livio Trentin;Carlo Agostini;Monica Facco;Francesco Piazza

  • Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas

    Livio Trentin;Anna Cabrelle;Monica Facco;Davide Carollo

  • Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation

    Enrico Tiacci;Gianluca Schiavoni;Francesco Forconi;Alessia Santi

  • Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo

    Luigi Leanza;Matteo Romio;Katrin Anne Becker;Michele Azzolini

  • Bronchoalveolar lavage and lung histology: comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis

    G. Semenzato;Marco Chilosi;E. Ossi;L. Trentin

  • Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

    Viktor Ljungström;Diego Cortese;Emma Young;Tatjana Pandzic

  • High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia

    Gianpietro Carlo Semenzato;R Foa;Carlo Agostini;R Zambello

  • Multiple myeloma cell survival relies on high activity of protein kinase CK2

    Francesco A. Piazza;Maria Ruzzene;Carmela Gurrieri;Barbara Montini

Frequent Co-Authors

Gianpietro Semenzato
Gianpietro Semenzato University of Padua
Carlo Agostini
Carlo Agostini University of Padua
Giovanni Pizzolo
Giovanni Pizzolo University of Verona
Robin Foà
Robin Foà Sapienza University of Rome
Paolo Ghia
Paolo Ghia Vita-Salute San Raffaele University
Luca Laurenti
Luca Laurenti Catholic University of the Sacred Heart
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Andrea Cerutti
Andrea Cerutti Icahn School of Medicine at Mount Sinai
Šárka Pospíšilová
Šárka Pospíšilová Masaryk University
Richard Rosenquist
Richard Rosenquist Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, various online degrees and certifications offer promising career pathways. Nurses aiming to specialize can explore acute care np certification, which prepares professionals to handle complex patient care in critical settings. This certification is ideal for those seeking to advance their clinical skills in acute medical environments.

Accelerated programs also provide a faster route into advanced nursing roles. Many registered nurses benefit from accelerated rn to np programs, enabling them to become nurse practitioners efficiently while balancing work and study. These programs emphasize hands-on learning supported by online flexibility.

For individuals without prior nursing experience, 12-month accelerated nursing programs online for non nurses provide a unique opportunity to enter the nursing field quickly. These streamlined courses cover essential nursing concepts and clinical practice in an intensive format.

Additionally, students seeking smoother admissions can find guidance through resources listing the easiest absn program to get into. These programs often have more accessible requirements, making them attractive for those eager to kickstart a nursing career.

Together, these options help build a strong foundation for careers that intersect with Immunology, offering both academic advancement and practical skill development in healthcare.

Best Scientists Citing Livio Trentin

Trending Scientists